Literature DB >> 29169283

Time-lapse microscopic observation of non-dividing cells in cultured human osteosarcoma MG-63 cell line.

John Dosch1, Elise Hadley1, Cal Wiese1, Marissa Soderberg1, Tori Houwman1, Kai Ding2, Alexandra Kharazova3, John L Collins4, Bart van Knippenberg5, Carl Gregory6, Alexander Kofman1,7.   

Abstract

Cancer stem cells resemble normal tissue-specific stem cells in many aspects, such as self-renewal and plasticity. Like their non-malignant counterparts, cancer stem cells are suggested to exhibit a relative quiescence. The established cancer cell lines reportedly harbor slow-proliferating cells that are positive for some cancer stem cells markers. However, the fate of these cells and their progeny remains unknown. We used time-lapse microscopy and the contrast-based segmentation algorithm to identify and monitor actively dividing and non-dividing cells in human osteosarcoma MG-63 cell line. Within the monitored field of view the non-dividing cells were represented by three cells that never divided, and one cell that attempted to divide, but failed cytokinesis, and later, after significantly prolonged division, produced the progeny with enlarged segmented nuclei, thus pointing to a possible mitotic catastrophe. Together, these cells initially constituted about 6.2% of the total number of seeded cells, yet only 0.02% of all cells at the end of the observation period when cells became confluent. Non-dividing cells were characterized by rounded shape, dark nuclei, random cytoplasmic streaming and subtle oscillatory movement, however, they did not migrate and rarely formed cell-cell contacts as compared to actively dividing cells. Our data indicate that the observed non-dividing MG-63 cells do not have a growth advantage over other cells and, therefore, they do not contribute to the cancer stem cells pool.

Entities:  

Keywords:  Non-dividing; aneuploidy; cancer; cell-cell interaction; quiescent; stem cells; time-lapse microscopy

Mesh:

Year:  2017        PMID: 29169283      PMCID: PMC5884383          DOI: 10.1080/15384101.2017.1395535

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  71 in total

1.  Human interferon: mass production in a newly established cell line, MG-63.

Authors:  A Billiau; V G Edy; H Heremans; J Van Damme; J Desmyter; J A Georgiades; P De Somer
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

Review 2.  Adult stem cell niches: cellular and molecular components.

Authors:  Amélie Rezza; Rachel Sennett; Michael Rendl
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

3.  Chemotherapy sorting can be used to identify cancer stem cell populations.

Authors:  Liping Li; Bingkun Li; Jialiang Shao; Xiang Wang
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

4.  A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy.

Authors:  Qin Mao; Yu Zhang; Xiaoyue Fu; Jianxin Xue; Wenhao Guo; Maobing Meng; Zongguang Zhou; Xianming Mo; You Lu
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-30       Impact factor: 4.553

5.  CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

Authors:  M-Q Gao; Y-P Choi; S Kang; J H Youn; N-H Cho
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

6.  Accumulation of a differentiation regulator specifies transit amplifying division number in an adult stem cell lineage.

Authors:  Megan L Insco; Arlene Leon; Cheuk Ho Tam; Dennis M McKearin; Margaret T Fuller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

7.  Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

Authors:  Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Giovanni Mazzarol; Manuela Vecchi; Simona Ronzoni; Loris Bernard; Giuseppe Viale; Pier Giuseppe Pelicci; Pier Paolo Di Fiore
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

8.  Human embryonic and neuronal stem cell markers in retinoblastoma.

Authors:  Gail M Seigel; Abigail S Hackam; Arupa Ganguly; Lorrie M Mandell; Federico Gonzalez-Fernandez
Journal:  Mol Vis       Date:  2007-06-08       Impact factor: 2.367

9.  CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent.

Authors:  Yirui Sun; Weiqing Kong; Anna Falk; Jin Hu; Liangfu Zhou; Steve Pollard; Austin Smith
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240

10.  Transient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma.

Authors:  Pauline Ostyn; Raja El Machhour; Severine Begard; Nuria Kotecki; Jerome Vandomme; Pilar Flamenco; Pascaline Segard; Bernadette Masselot; Pierre Formstecher; Yasmine Touil; Renata Polakowska
Journal:  Cell Commun Signal       Date:  2014-09-17       Impact factor: 5.712

View more
  1 in total

Review 1.  Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.

Authors:  Sara R Martins-Neves; Gabriela Sampaio-Ribeiro; Célia M F Gomes
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.